Registration - Organization
Pharmascience Inc. / David Goodman, Chief Executive Officer
Registration Information
Senior Officer Name: David Goodman, Chief Executive Officer
Senior Officer Change History
Initial registration start date: 2020-05-04
Registration status: Active
Projected end date: No date provided
Registration number: 6454-3279
Associated Lobbying Activity Reports
Total number of Lobbying Activity Reports: 0
Lobbying Activity Reports - last 6 months: 0
Version 8 of 12 (2023-11-24 to 2024-06-01)
Version 8 of 12 (2023-11-24 to 2024-06-01)
Lobbying Information
Details Regarding the Identified Subject Matter |
|||||||
| Will any of the lobbyists listed within this registration arrange a meeting between a public office holder and any other individual for the purpose of attempting to influence any of the matters listed below: | No | ||||||
|
|||||||
BC Ministries/Provincial Entities
- Health
- Mental Health and Addictions
- Provincial Health Services Authority
- Vancouver Coastal Health Authority
Organization Details
Senior Officer Name and Position during the Period of this Registration
Martin Arès, Chief Executive Officer
Organization Contact Information
Pharmascience Inc.
Address:
6111 Royalmount Avenue
Montreal, QC H4P 2T4
Canada
Description of Activities
Pharmaceutical Manufacturer
Gifts or benefits provided by the organization
| Name | Gift or Benefit Description | Circumstance | Date Promised | Value Promised | Date Given | Value Given |
|---|---|---|---|---|---|---|
| No Records | ||||||
Contributors to the Lobbying Activity
No person or organization contributed over $1000CDN, within the preceding 12 months, toward the lobbying activity on behalf of the organization that has a direct interest in the outcome of the lobbying activity.
Government Funding in the Last 12 Months
Received Government Funding
The Received Government Funding table below is not intended to be additive. Adding all of the entries together does not necessarily provide an accurate sum of all government funding received. There may be redundancy (reporting of the same funding more than once) caused by overlap in the "Date/Period Received" between 2 or more entries.
| Source of Government Funding | Funding Received | Date/Period Received |
|---|---|---|
| Canada Economic Developement for Quebec Regions | $639,633.00 | 2023-09-12 to 2026-12-31 |
| Investissement Québec | $94,719.38 | 2022-12-19 |
Other Entities (working together for the purposes of lobbying) Information
Pharmascience Inc. is not working together with any other entity for the purpose of lobbying.
Affiliates with a Direct Interest in the Outcome
Pharmascience Inc. does not have any affiliates that could have a direct interest in the outcome of the lobbying activities
Other Persons or Organizations with Direct Interests
The activities of Pharmascience Inc. are not controlled or directed by another person or organization with a direct interest in the outcome of this undertaking.
Lobbyists Details
| Lobbyist | Contributions | ||
|---|---|---|---|
|
Martin Arès Subscribes to a Code of Conduct: No Former Public Office Holder in BC: No |
|
||
|
Sarah E Douglas Subscribes to a Code of Conduct: No Former Public Office Holder in BC: No |
|
||
|
David Goodman Subscribes to a Code of Conduct: No Former Public Office Holder in BC: No |
|
- Date Modified: